Novartis | NOVN - Trade Debtors

Stock Price
102.32
Daily Change
-1.66 -1.60%
Monthly
6.56%
Yearly
2.73%
Q3 Forecast
103.29

Novartis reported $9.18B in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Alcon AG USD 2.02B 158M Jun/2025
Almirall EUR 193.8M 20.72M Jun/2025
Amgen USD 8.7B 569M Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Autolus Therapeutics Ltd 32.53M 32.81M Jun/2025
Bayer EUR 17.64B 895M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Fresenius EUR 4.06B 122M Jun/2025
Fresenius Medical Care EUR 3.23B 333.55M Jun/2025
Galapagos EUR 223.52M 140.03M Jun/2025
Genmab DKK 998M 199M Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
GRIFOLS EUR 1.25B 213.13M Jun/2025
Hikma Pharmaceutical USD 973M 8M Dec/2024
J&J USD 16.02B 1.18B Mar/2025
Lonza CHF 1.33B 269M Dec/2024
Merck EUR 4.92B 62M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Novartis USD 9.18B 451M Jun/2025
Novartis USD 9.18B 1.62B Jun/2025
Novo Nordisk 90.28B 3.92B Jun/2025
Orion EUR 382.3M 9M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Philips EUR 3.58B 100M Jun/2025
Recordati EUR 700.23M 6.1M Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi EUR 8.21B 7.76B Jun/2025
UCB EUR 1.58B 157M Dec/2024